These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17665159)

  • 1. VMAT2 gene expression and function as it applies to imaging beta-cell mass.
    Harris PE; Ferrara C; Barba P; Polito T; Freeby M; Maffei A
    J Mol Med (Berl); 2008 Jan; 86(1):5-16. PubMed ID: 17665159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.
    Freeby M; Ichise M; Harris PE
    Islets; 2012; 4(6):393-7. PubMed ID: 23221614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.
    Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E
    Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
    Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
    Souza F; Simpson N; Raffo A; Saxena C; Maffei A; Hardy M; Kilbourn M; Goland R; Leibel R; Mann JJ; Van Heertum R; Harris PE
    J Clin Invest; 2006 Jun; 116(6):1506-13. PubMed ID: 16710474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
    Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
    Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of beta-cell mass and function.
    Ichise M; Harris PE
    J Nucl Med; 2010 Jul; 51(7):1001-4. PubMed ID: 20554742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas.
    Saisho Y; Harris PE; Butler AE; Galasso R; Gurlo T; Rizza RA; Butler PC
    J Mol Histol; 2008 Oct; 39(5):543-51. PubMed ID: 18791800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing pancreatic beta-cell mass with [11C]DTBZ.
    Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE
    Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives of vesicular monoamine transporter 2 chemical characteristics in mammals and its constant expression in type 1 diabetes rat models.
    Hong F; Liu L; Fan RF; Chen Y; Chen H; Zheng RP; Zhang Y; Gao Y; Zhu JX
    Transl Res; 2014 Feb; 163(2):171-82. PubMed ID: 24161354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
    Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
    J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.
    Eriksson O; Jahan M; Johnström P; Korsgren O; Sundin A; Halldin C; Johansson L
    Nucl Med Biol; 2010 Apr; 37(3):357-63. PubMed ID: 20346875
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.